Production of insulin secreting cells derived from induced pluripotent stem cells for the treatment of Type 1 diabetes mellitus by cellular replacement therapy.

生产源自诱导多能干细胞的胰岛素分泌细胞，用于通过细胞替代疗法治疗 1 型糖尿病。

• 批准号: 199307
• 负责人: Glew Riley A
• 金额: $ 1.27万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-02-01 至 2011-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=199307&lang=en
• 关键词: Cellular Therapeutics; Developmental Biology; Differentiation; Regenerative Medicine; Stem Cells

Type 1 diabetes mellitus is a widespread disease that could potentially be treated through regenerative medicine. A promising treatment strategy is to transplant replacement cells capable of insulin production and secretion. By replacing these cells it

1 型糖尿病是一种普遍存在的疾病，可以通过再生医学进行治疗。 一种有前途的治疗策略是移植能够产生和分泌胰岛素的替代细胞。 通过更换这些细胞